Mesenchymal stem cells (Tianjin Weikai Bioeng)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameMesenchymal stem cells (Tianjin Weikai Bioeng)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAcute-On-Chronic Liver Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Weikai Bioeng Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Weikai Bioeng Ltd
Active IndicationsN/A
Inactive IndicationsAcute-On-Chronic Liver Failure

Other Information

ATC CodeN/A
Related LinksN/A